Journal of Clinical & Experimental Dermatology Research
Open Access

Mario Puviani

Publications

• Research Article
  Efficacy of a Corticosteroid-Free, 5% Hyaluronic-Based Facial Cream in the Treatment of Seborrheic Dermatitis. A Proof-of-Concept Study
  Author(s): Massimo Milani, Antonio Barcella, Mario Puviani Massimo Milani, Antonio Barcella, Mario Puviani
  
  Introduction: Seborrheic Dermatitis (SD) is a very common skin disease. This papulo-squamous disorder characterized by erythema, itch, and flaking, affects sebum-rich areas such as scalp, trunk and face. Topical steroids are commonly used as first line therapy of SD but their long-term use, especially when face is involved, could have untoward side effects like skin atrophy, acne and telangiectasia. Local tolerability and long-term safety concerns limit the use of calcineurin inhibitors. Hyaluronic acid topical formulations, thanks to its hydrating and several skin cellular modulation effects have shown to reduce skin inflammation and improve the clinical course of SD. A new cream formulation of HA 5% (Eutrosis DS, Difa Cooper, IFC Group; EDS) has been recently developed. Study aim: To evaluate in a proof-of-concept study the efficacy and toler.. View More»
  DOI: 10.4172/2155-9554.1000426

  Abstract PDF

Relevant Topics